Pharma Pulse 3/6/25: Regulatory Agencies Role in Battle Against Misinformation, Developing Winning Supplemental Benefits Packages & more
The Role Regulatory Agencies Should Play in the Battle Against Misinformation
In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, explores what kind of role regulatory agencies should play in the battle against misinformation.
Developing Winning Supplemental Benefits Packages
Facing a variety of financial pressures, health plans need to take a measured approach to identify supplemental benefit strategies that facilitate their success.
AI Drug Firm Recursion Wants to Be Amazon Prime of Pharma
AI drug developer Recursion Pharmaceuticals Inc. is considering an Amazon Prime-style subscription model for selling its pipeline of medicines.
MedaSystems announced additional funding from existing investors, Debiopharm Innovation Fund, Nina Capital, and Young Sohn, a co-founder of Veeva Systems. This investment underscores confidence in MedaSystems’ ability to modernize pre-approval access pathways through its AI-driven workflow platform. By streamlining Expanded Access and IIS workflows, MedaSystems helps pharmaceutical companies and healthcare providers efficiently manage requests, improve patient access, and capture real-world data to support evidence generation and regulatory submissions.
#TuftsMedicine @TuftsCEVR @jchambers241 talks with @PharmaCommerce about how #biosimilars cut costs, expand patient access and shape the market. He breaks down challenges, solutions and what’s next in the space.
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs
